Organization
Ligand Pharmaceuticals, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Ligand Pharmaceuticals, Inc.
... & Chief Scientific Officer, Single Cell Technology 18.3. Christel Iffland, Vice President, Ligand Pharmaceuticals 18.2. Aaron Sato, Chief Scientific Officer, LakePharma 18.1. Chapter Overview 18. ...
... many notable public and private life sciences companies and charitable foundations, including Ligand Pharmaceuticals and the Therapeutics Board of the Cystic Fibrosis Foundation. "We believe ...
... raised £10 million, too. Vernalis accepted a £33 million buyout bid from Ligand Pharmaceuticals. And more.—Nick Taylor 1. Pfizer pays BioNTech $120M to form mRNA ...
... Ligand Pharmaceuticals is set to acquire Vernalis for the knockdown price of £33 ...
... Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) and Vernalis plc (LSE: VER) announce that Ligand has declared ...
Subscribe now for full coverage on Ligand Pharmaceuticals, Inc.
Start My Free Trial